中医临床研究
中醫臨床研究
중의림상연구
CLINICAL JOURNAL OF CHINESE MEDICINE
2014年
23期
123-125
,共3页
酪酸梭菌活菌散%蒙托石散%婴幼儿病毒性腹泻
酪痠梭菌活菌散%矇託石散%嬰幼兒病毒性腹瀉
락산사균활균산%몽탁석산%영유인병독성복사
Clostridium butyricum powder%Montmorillonite powder%Viral diarrhea in infants
目的:探讨酪酸梭菌活菌散与蒙托石散间隔联用治疗婴幼儿病毒性腹泻的临床疗效。方法:120例病毒性腹泻患儿随机分为观察组和对照组,各60例,对照组给予饮食调节、抗病毒以及维持水电解质、酸碱平衡等对症支持治疗,观察组同时给予酪酸梭菌活菌散与蒙托石散间隔联用治疗。结果:观察组总有效率明显高于对照组(P<0.01);观察组患儿体温、便性状、便次和便化验恢复正常时间均显著短于对照组(P<0.01);两组患儿治疗后血浆VIP水平和肠黏膜5-HT的表达明显下降,NPY水平明显提高,其中观察组各项指标变化与对照组比较有统计学差异(P<0.05);观察组患儿腹痛、肠鸣音异常、脱水及电解质紊乱等不良反应发生率均明显低于对照组(P<0.05或0.01)。结论:酪酸梭菌活菌散与蒙托石散间隔联用治疗婴幼儿病毒性腹泻疗效确切,不良反应少,值得临床推广。
目的:探討酪痠梭菌活菌散與矇託石散間隔聯用治療嬰幼兒病毒性腹瀉的臨床療效。方法:120例病毒性腹瀉患兒隨機分為觀察組和對照組,各60例,對照組給予飲食調節、抗病毒以及維持水電解質、痠堿平衡等對癥支持治療,觀察組同時給予酪痠梭菌活菌散與矇託石散間隔聯用治療。結果:觀察組總有效率明顯高于對照組(P<0.01);觀察組患兒體溫、便性狀、便次和便化驗恢複正常時間均顯著短于對照組(P<0.01);兩組患兒治療後血漿VIP水平和腸黏膜5-HT的錶達明顯下降,NPY水平明顯提高,其中觀察組各項指標變化與對照組比較有統計學差異(P<0.05);觀察組患兒腹痛、腸鳴音異常、脫水及電解質紊亂等不良反應髮生率均明顯低于對照組(P<0.05或0.01)。結論:酪痠梭菌活菌散與矇託石散間隔聯用治療嬰幼兒病毒性腹瀉療效確切,不良反應少,值得臨床推廣。
목적:탐토락산사균활균산여몽탁석산간격련용치료영유인병독성복사적림상료효。방법:120례병독성복사환인수궤분위관찰조화대조조,각60례,대조조급여음식조절、항병독이급유지수전해질、산감평형등대증지지치료,관찰조동시급여락산사균활균산여몽탁석산간격련용치료。결과:관찰조총유효솔명현고우대조조(P<0.01);관찰조환인체온、편성상、편차화편화험회복정상시간균현저단우대조조(P<0.01);량조환인치료후혈장VIP수평화장점막5-HT적표체명현하강,NPY수평명현제고,기중관찰조각항지표변화여대조조비교유통계학차이(P<0.05);관찰조환인복통、장명음이상、탈수급전해질문란등불량반응발생솔균명현저우대조조(P<0.05혹0.01)。결론:락산사균활균산여몽탁석산간격련용치료영유인병독성복사료효학절,불량반응소,치득림상추엄。
Objective:To discuss clinical effects of clostridium butyricum powder together with montmorillonite powder on viral diarrhea in infants. Methods: 120 patients were randomly divided into the observation group (60 patients) and the control group (60 patients), the control group was given supportive treatment, such as diet modification, anti-virus and maintaining water and electrolyte, acid-base balance;the observation group was given clostridium butyricum powder together with montmorillonite powder more. Results:The total efficiency in the observation group was significantly better than that in the control (P<0.01);clinical symptoms and data were improved in the observation better than that in the control (P<0.05 or 0.01). Conclusion:The efficacy of clostridium butyricum powder plus montmorillonite powder was confirmed with fewer side effects, and was worthy of clinical promotion.